Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Hospitalier Universitaire Dijon | OTHER |
Not provided
Not provided
Not provided
Not provided
The objective of fluid challenge is to increase oxygen delivery (DO2) in order to improve/restore tissue oxygen consumption (VO2). However the fluid challenge volume to administer stills in debate, some studies recommend to administer 250 mL. Previous studies suggested that 500 mL of fluid challenge administration may improve cardiac output and oxygen delivery. The relation between the amount of fluid expansion and oxygen delivery and oxygen consumption was not yet been studied in a randomized study in critical care patients. This is the purpose of this study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 250 mL of fluid challenge | Active Comparator |
| |
| 500 mL of fluid challenge | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fluid challenge | Other | After randomisation, patient will receive 250 ml or 500 ml of fluid challenge. VO2 will be assessed before fluid challenge, immediately, 30 minutes and 60 minutes after fluid challenge. |
| Measure | Description | Time Frame |
|---|---|---|
| VO2 after fluid challenge | Tissue oxygen consumption (VO2) after fluid challenge | 30 minutes after fluid challenge. |
| VO2 after fluid challenge | Tissue oxygen consumption (VO2) after fluid challenge | 60 minutes after fluid challenge. |
| Measure | Description | Time Frame |
|---|---|---|
| Change of arterial lactate concentration from baseline | Baseline is the measurement of arterial lactate concentration immediately after fluid challenge | 30 minutes after fluid challenge. |
| Change of arterial lactate concentration from baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Osama Abou-Arab, Dr | CHU Amiens | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Amiens Picardie | Amiens | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Baseline is the measurement of arterial lactate concentration immediately after fluid challenge
| 60 minutes after fluid challenge. |
| Respiratory variation of stroke volume | Respiratory variation of stroke volume after fluid challenge. | Immediately, 30 and 60 minutes after fluid challenge. |
| PaO2/FiO2 | PaO2/FiO2 ratio (ratio of arterial oxygen partial pressure to fractional inspired oxygen) after fluid challenge | Immediately, 30 and 60 minutes after fluid challenge. |
| Respiratory variation of the pulse pressure | Respiratory variation of the pulse pressure | 30 and 60 minutes after fluid challenge. |
| Stroke volume variation with passive leg raising (PLV) | Stroke volume variation with passive leg raising (PLV) | 30 and 60 minutes after fluid challenge. |
| Systolic heart function (LVEF) | Systolic heart function (LVEF) | Immediately, 30 and 60 minutes after fluid challenge. |
| Diastolic heart function | Diastolic heart function (E, A, E', A', S' waves) | Immediately, 30 and 60 minutes after fluid challenge. |